Thermage, which makes noninvasive devices to tighten and resurface aging skin and abdomens, lowered the range for its IPO on Thursday. The company will still offer 6 million shares but at a range of $8-$9 as opposed to the planned $11-$13 range. Merrill Lynch is managing the deal which is now expected to price tonight.
